Dapagliflozin propanediol monohydrate 12.3 mg equivalent to Dapagliflozin 10 mg; Metformin hydrochloride 500 mg (with 0.5% Magnesium stearate);   - search results

forxiga 10 mg

astrazeneca (israel) ltd - dapagliflozin propanediol - film coated tablets - dapagliflozin propanediol 12.30 mg/dose - dapagliflozin - forxiga is indicated:- in adults aged 18 years and older for the treatment of insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise •as monotherapy when metformin is considered inappropriate due to intolerance. •in addition to other medicinal products for the treatment of type 2 diabetes. - to reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure (nyha class ii-iv) with reduced ejection fraction- to reduce the risk of sustained egfr decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression. limitations of use -forxiga is not recommended for the treatment of chronic kidney disease in patients with polycystic kidney disease or patients requiring or with a recent history of immunosuppressive therapy for kidney disease. forxiga is not expected to be effective in these populations.